Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration
- PMID: 9103468
Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration
Abstract
To determine the effects of IL-10 on cytokine and granulocyte responses during endotoxemia, two groups of eight healthy male volunteers were challenged with endotoxin (4 ng/kg) on two occasions, once in combination with placebo injection, and once in conjunction with i.v. administered recombinant human IL-10 (rhIL-10) (25 microg/kg). In group 1, rhIL-10 was administered 2 min before endotoxin challenge; in group 2, the intervention was delayed for 1 h after endotoxin administration. rhIL-10 pretreatment reduced the LPS-induced rises in temperature and release of TNF, IL-6, IL-8, and IL-1 receptor antagonist. Endotoxin-induced granulocyte accumulation in lungs, as determined by dynamic granuloscintigrams, was prevented by rhIL-10 pretreatment, whereas granulocyte recruitment in liver and spleen was only modestly reduced. In addition, granulocyte degranulation, as measured by plasma elastase/alpha1-antitrypsin complexes, was blunted significantly by rhIL-10 pretreatment. Post-treatment with rhIL-10 did not influence LPS-induced temperature responses, cytokine release, or granulocyte degranulation. Both rhIL-10 pretreatment and post-treatment reduced LPS-induced cortisol levels. These results indicate that pretreatment with rhIL-10 reduces endotoxin-induced febrile responses, cytokine responses, and granulocyte accumulation in lungs, while in this acute model post-treatment with rhIL-10 exerts limited anti-inflammatory effects.
Similar articles
-
Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia.J Immunol. 1997 Feb 15;158(4):1971-5. J Immunol. 1997. PMID: 9029140
-
Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor.J Immunol. 1997 Feb 1;158(3):1490-7. J Immunol. 1997. PMID: 9013996
-
Effect of endogenous nitric oxide on tumour necrosis factor-alpha-induced leukosequestration and IL-8 release in guinea-pigs airways in vivo.Br J Pharmacol. 1997 Sep;122(1):103-11. doi: 10.1038/sj.bjp.0701338. Br J Pharmacol. 1997. PMID: 9298535 Free PMC article.
-
Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration.J Immunol. 1995 Nov 15;155(10):5038-45. J Immunol. 1995. PMID: 7594512 Clinical Trial.
-
Anti-inflammatory effects of intravenous anesthetics on endotoxemia.Mini Rev Med Chem. 2005 Mar;5(3):241-5. doi: 10.2174/1389557053175407. Mini Rev Med Chem. 2005. PMID: 15777258 Review.
Cited by
-
Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression.J Biol Chem. 2011 May 6;286(18):16374-85. doi: 10.1074/jbc.M110.207738. Epub 2011 Mar 18. J Biol Chem. 2011. PMID: 21454555 Free PMC article.
-
Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.Immunology. 2004 Nov;113(3):281-92. doi: 10.1111/j.1365-2567.2004.01988.x. Immunology. 2004. PMID: 15500614 Free PMC article. Review.
-
Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms.Immunol Rev. 2008 Dec;226:41-56. doi: 10.1111/j.1600-065X.2008.00707.x. Immunol Rev. 2008. PMID: 19161415 Free PMC article. Review.
-
Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases.Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):525-34. doi: 10.1161/ATVBAHA.114.304455. Epub 2014 Dec 30. Arterioscler Thromb Vasc Biol. 2015. PMID: 25550206 Free PMC article. Review.
-
Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis.Pharm Res. 2004 Nov;21(11):2072-8. doi: 10.1023/b:pham.0000048199.94510.b0. Pharm Res. 2004. PMID: 15587930
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources